Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914190-12-000256
Filing Date
2012-04-02
Accepted
2012-04-02 16:20:30
Documents
1
Period of Report
2012-03-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 23465
  Complete submission text file 0000914190-12-000256.txt   24945
Mailing Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402
Business Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402 650-458-2678
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NILE THERAPEUTICS, INC. 122 OCEAN PARK BLVD., SUITE 307 SANTA MONICA CA 90405
Business Address
Evans Daron (Reporting) CIK: 0001411726 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 12733519